State Of Wyoming Graphite Bio, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.47 - $3.38 $190 - $260	77 Added 43.26%	255 $0
Q1 2023 May 12, 2023	SELL	$1.85 - $3.21 $12 - $22	-7 Reduced 3.78%	178 $0
Q4 2022 Feb 14, 2023	BUY	$2.82 - $3.59 $380 - $484	135 Added 270.0%	185 $0
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $141 - $212	50 New	50 $0

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.